Trial · NCT01191541
Adverse events112
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 112
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | extremity oedema | General disorders | All the Patients at Presentation | 0 | 65 | 0 |
| other | extremity oedema | General disorders | the Adverse Events Associated With ATRA | 0 | 65 | 0 |
| other | extremity oedema | General disorders | the Adverse Events Associated With ATO | 9 | 65 | 9 |
| other | extremity oedema | General disorders | Consolidation: IDA | 0 | 65 | 0 |
| other | extremity oedema | General disorders | Consolidation: ATO | 0 | 65 | 0 |
| other | extremity oedema | General disorders | Consolidation: DNR (No Ara-c Group) | 0 | 35 | 0 |
| other | extremity oedema | General disorders | Consolidation: DNR+Ara-c (Ara-C Group) | 0 | 30 | 0 |
| other | extremity oedema | General disorders | Maintenance: ATRA+MTX+6-MP | 0 | 65 | 0 |
| other | nausea | Gastrointestinal disorders | All the Patients at Presentation | 0 | 65 | 0 |
| other | nausea | Gastrointestinal disorders | the Adverse Events Associated With ATRA | 7 | 65 | 7 |
| other | nausea | Gastrointestinal disorders | the Adverse Events Associated With ATO | 2 | 65 | 2 |
| other | nausea | Gastrointestinal disorders | Consolidation: IDA | 0 | 65 | 0 |
| other | nausea | Gastrointestinal disorders | Consolidation: ATO | 0 | 65 | 0 |
| other | nausea | Gastrointestinal disorders | Consolidation: DNR (No Ara-c Group) | 0 | 35 | 0 |
| other | nausea | Gastrointestinal disorders | Consolidation: DNR+Ara-c (Ara-C Group) | 0 | 30 | 0 |
| other | nausea | Gastrointestinal disorders | Maintenance: ATRA+MTX+6-MP | 0 | 65 | 0 |
| other | skin pigmentation | Skin and subcutaneous tissue disorders | All the Patients at Presentation | 0 | 65 | 0 |
| other | skin pigmentation | Skin and subcutaneous tissue disorders | the Adverse Events Associated With ATRA | 7 | 65 | 7 |
| other | skin pigmentation | Skin and subcutaneous tissue disorders | the Adverse Events Associated With ATO | 2 | 65 | 2 |
| other | skin pigmentation | Skin and subcutaneous tissue disorders | Consolidation: IDA | 0 | 65 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01191541/events